Related Experiment Video
Updated: May 20, 2026

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
Published on: November 10, 2021
4-1BB-mediated signals confer protection against folic acid-induced nephrotoxicity
Xiaozhong Li1, Jihong Dai, Yuhua Qiu
1Children Hospital & Medical Bio-tech Institute Affiliated to Soochow University, #303 Jingde Road, Suzhou Jiangsu 215003, China. xiaozhonglicn@yeah.net
Background:
The role of co-stimulatory molecules in renal diseases has been previously examined, however, little is known about the role of 4-1BB in the context of renal diseases resulting from nonimmune-mediated tubulointerstitial fibrosis. Folic acid induced Nephrotoxicity (FAN) in mice was used to explore the role of 4-1BB in this setting.
Methods:
CD1 mice were treated with folic acid and kidneys subsequently examined using histochemistry, in addition to defining T cell profiles and evaluating renal function. Increased CD3+ and CD4+ T lymphocytes present in blood and spleen at day 3 suggested immunopathological reactions during the early stages of FAN and decreased CD3+ and CD4+ T lymphocytes on day 14 were characteristic of an immunocompromised state observed during the late stages of FAN.
Results:
After 14 days of co-treatment with agonistic anti-4-1BB monoclonal antibodies, renal tubulointerstitial lesions were reduced. Renal function was improved, with Bun scores decreasing (p<0.01) and sCr levels decreasing (p<0.01). CD3+ and CD4+ T lymphocytes levels were increased during the early stages of disease in FA treated mice and reduced to the normal level in the 4-1BB-treated mice. CD3+ and CD4+ T lymphocytes levels were decreased in FA treated mice and returned to baseline in the 4-1BB-treated mice during later stages.
Conclusions:
Data presented in this report demonstrated that 4-1BB signals had immunoregulatory effects that attenuated early immune-mediated pathology and reversed the immunocompromised state observed during the later stages of disease.
Insights
Targeting 4-1BB (a co-stimulatory molecule) in folic acid-induced nephrotoxicity reduced kidney damage and improved renal function. This approach attenuated early immune pathology and reversed later-stage immune suppression in mice.
Area of Science:
- Nephrology
- Immunology
- Molecular Biology
Background:
- The role of co-stimulatory molecules in renal diseases is not fully understood, particularly 4-1BB in nonimmune-mediated tubulointerstitial fibrosis.
- Folic acid-induced nephrotoxicity (FAN) in mice serves as a model to investigate 4-1BB's function in renal disease.
Purpose of the Study:
- To explore the role of the co-stimulatory molecule 4-1BB in folic acid-induced nephrotoxicity.
- To evaluate the therapeutic potential of targeting 4-1BB in a mouse model of renal tubulointerstitial fibrosis.
Main Methods:
- CD1 mice were administered folic acid to induce nephrotoxicity.
- Kidneys were analyzed using histochemistry, T cell profiling, and renal function tests.
- Mice were co-treated with agonistic anti-4-1BB monoclonal antibodies.
Main Results:
- Co-treatment with anti-4-1BB antibodies reduced renal tubulointerstitial lesions and improved renal function (decreased BUN and sCr levels).
- 4-1BB treatment modulated T cell profiles, attenuating early-stage immunopathology and reversing late-stage immunosuppression.
- Histochemistry revealed reduced kidney damage in 4-1BB treated mice.
Conclusions:
- 4-1BB signaling exerts immunoregulatory effects in the context of folic acid-induced nephrotoxicity.
- Targeting 4-1BB can attenuate early immune-mediated pathology and reverse the immunocompromised state in later disease stages.
- These findings suggest 4-1BB as a potential therapeutic target for nonimmune-mediated renal tubulointerstitial fibrosis.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Inhibitors of Bacterial Protein Synthesis
Antifungal Agents
Biosynthesis of Nucleic Acids
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Acute Kidney Injury IV: Diagnostic Studies and Prevention
